Boston Scientific Announces Results For Second Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Boston Scientific (BSX) PT Raised to $47 at Cowen
July 24, 2019 3:34 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $47.00 (from $42.00) while maintaining an Outperform rating.
The analyst commented, "While 2Q organic revenue growth of 6.3% was below the midpoint of guidance for 6%-7%, BSX has a steady flow... More
Boston Scientific (BSX) Tops Q2 EPS by 1c
July 24, 2019 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.63 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Boston Scientific sees Q3 2019 EPS of $0.37-$0.39, versus the consensus of... More
